



- Stock: In Stock
- Model: 179664
0% Customers recommend this product
-
5 Awesome0%
-
4 Great0%
-
3 Average0%
-
2 Bad0%
-
1 Poor0%
Reviews Over Dorzopt Plus cap. eye. solution fl. 5 ml No. 1
- (0)
Total Reviews (0)
click here write review to add review for this product.
Report this review.
Description
Drug is shown for treatment of the increased intraocular pressure at patients with an open angle glaucoma or pseudo-exfoliative glaucoma when topical administration is only not enough beta-blockers.
Structure
active ingredients: dorzolamid; Timololum;
1 ml of drops eye, the solution containing 20 mg dorzolamidy in the form of 22.26 mg dorzolamidy a hydrochloride and 5 mg of Timololum in the form of 6.84 mg of Timololum of a maleate;
excipients: hydroxyethylcellulose; citric acid monohydrate, sodium hydroxide of 1 M solution Mannitolum (E 421) benzalkoniya chloride, 1 M solution of sodium of hydroxide or hydrochloric acid; the water purified.
toContraindication
toDrug is contraindicated to patients with:
- reactive respiratory diseases, including bronchial asthma or bronchial asthma in the anamnesis, or a serious chronic obstructive illness of lungs;
- sinus bradycardia, a sick sinus syndrome, sinuatrial the block, AV blockade of II or III degree, it is not controlled by a pacemaker, the expressed heart failure, cardiogenic shock;
- heavy renal failure (clearance of creatinine (CrCl) <30 ml/min.) or giperkhloremichesky acidosis;
- hypersensitivity to one or both active ingredients, or to any of medicine components and also during pregnancy and feeding by a breast.
on information on separate active components and are not specific to a combination.
Route of administration
byDORZOPT PLUS are appointed on 1 drop in a conjunctival sac of affected eye (eyes) by 2 times a day.
If at the same time use other local ophthalmologic drug, the interval between burying medicine of DORZOPT PLUS and other medicine has to make not less than 10 minutes.
Feature of application
Pregnant women
use Drug during pregnancy.
Children
do not apply.
Overdose
Is not present data on overdose of medicine at accidental or its deliberate ingestion.
Side reactions
it is rare: symptoms of system allergic reactions, including Quincke's disease, small tortoiseshell, itch, rash, anaphylactic reactions.
Storage conditionsto Store
in original packing at a temperature not above 25 °C
to Store out of children's reach.
Expiration date. 2 years.
After opening of a bottle to use medicament no more than 4 weeks.
Specifications
Characteristics | |
Active ingredients | Dorzolamid, Timololum |
Applicant | Rompharm |
Code of automatic telephone exchange | S01ED51 Timololum, combinations |
Interaction with food | It doesn't matter |
Light sensitivity | Not sensitive |
Market status | Traditional |
Origin | Chemical |
Prescription status | According to the prescription |
Primary packing | bottle |
Producer | ROMFARM COMPANY OF K.O. |
Quantity in packing | 5 ml |
Release form | eye drops |
Route of administration | Eye |
Sign | Import |
Storage temperature | from 5 °C to 25 °C |
Trade name | Dorzopt |